- Published at
- by manilatimes.net
neutral
neutral
News for Autolus Therapeutics plc (AUTL)
- Published at
- by manilatimes.net
neutralneutral- Published at
- by gurufocus.com
negativenegativeAutolus Therapeutics Provides Business Updates and 2025 Overview
- Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th - National Comprehensive Cancer Network® add- Published at
- by manilatimes.net
negativenegative- Published at
- by gurufocus.com
neutralneutralAutolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine
High overall response rate: 76.6% of patients in the pivotal cohort achieved CR/Cri following treatment with obe-cel with a median follow-up of 20.3 monthsLow i- Published at
- by seekingalpha.com
positivepositiveAUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market
Autolus Therapeutics' AUCATZYL shows strong potential despite safety concerns. Find out why AUTL stock is a Buy.- Published at
- by investing.com
positivepositiveAutolus stock touches 52-week low at $3.05 amid market challenges By Investing.com
Autolus stock touches 52-week low at $3.05 amid market challenges- Published at
- by seekingalpha.com
neutralneutralAutolus Therapeutics plc (AUTL) Q3 2024 Earnings Call Transcript
Autolus Therapeutics plc (NASDAQ:AUTL) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ETCompany ParticipantsOlivia Manser - Director-Investor...- Published at
- by seekingalpha.com
neutralneutralAutolus Therapeutics plc 2024 Q3 - Results - Earnings Call Presentation (NASDAQ:AUTL)
The following slide deck was published by Autolus Therapeutics plc in conjunction with their 2024 Q3 earnings call.- Published at
- by benzinga.com
mixedmixedWhy Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket - Revelation Biosciences (NASDAQ:REVB)
Shares of Revelation Biosciences, Inc. REVB rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS results...- Published at
- by manilatimes.net
mixedmixed- Published at
- by investing.com
mixedmixed- Published at
- by globenewswire.com
mixedmixedLucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today
Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK – 2 September 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford...- Published at
- by seekingalpha.com
mixedmixedUndercovered Dozen: Burberry, Vinci SA, Lyft, PureCycle +
We share 12 ideas published last week focused on stocks with less coverage on Seeking Alpha. Explore more details here.- Published at
- by benzinga.com
mixedmixedWhy Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Cracker Barrel Old (NASDAQ:CBRL)
Loading... Loading... Shares of Cracker Barrel Old Country Store, Inc. CBRL fell sharply during Friday's session after the company reduced its dividend and sai...- Published at
- by marketscreener.com
mixedmixedAutolus Therapeutics Announces Changes to its Board of Directors
LONDON, April 01, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the appointment of Mike...- Published at
- by investing.com
mixedmixedCORRECTION “ AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee By Investing.com
CORRECTION “ AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee- Published at
- by globenewswire.com
mixedmixedAVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of...- Published at
- by insidermonkey.com
mixedmixed- Published at
- by globenewswire.com
mixedmixedAutolus Therapeutics Announces Changes to its Board of Directors
Autolus Therapeutics Announces Changes to its Board of Directors...